# Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults

> **NCT07352865** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Qingyuan Zhan** · enrollment: 100 (estimated)

## Conditions studied

- Psittacosis

## Interventions

- **DRUG:** Saline (0.9%, sterile, for infusion)
- **DRUG:** low dose Methylprednisolone
- **DRUG:** Moderate dose Methylprednisolone

## Key facts

- **NCT ID:** NCT07352865
- **Lead sponsor:** Qingyuan Zhan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352865, "Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07352865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*